Deutsche Bank’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Deutsche Bank’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-2,250	Closed	-$149K	–	5746
2014 Q4	$149K	Sell	2,250 -8,170	-78%	-$544K	﹤0.01%	4462
2014 Q3	$663K	Sell	10,420 -1,973	-16%	-$122K	﹤0.01%	3299
2014 Q2	$756K	Sell	12,393 -307	-2%	-$17.8K	﹤0.01%	3171
2014 Q1	$719K	Buy	12,700 +1,742	+16%	+$98.9K	﹤0.01%	3082
2013 Q4	$586K	Sell	10,958 -10,896	-50%	-$545K	﹤0.01%	2991
2013 Q3	$1M	Buy	21,854 +11,378	+109%	+$519K	﹤0.01%	2971
2013 Q2	$442K	Buy	+10,476	New	+$436K	﹤0.01%	3249

Other funds holding PJP

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

NCM

Niemann Capital Management Stateline, Nevada $788K AUM 23.27% 1-Year Est. Return

FIG

FundX Investment Group San Francisco, California $411M AUM 22.05% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

Deutsche Bank's PJP Position: Q1 2015 in Review

Deutsche Bank sold out of Invesco Pharmaceuticals ETF (PJP) in Q1 2015, closing a stake of 2,250 shares — an estimated $149K sold.

Deutsche Bank first reported a position in PJP in Q2 2013 and held it in 7 quarters. The position peaked at $1M in Q3 2013. 105 funds tracked by Wall St. Rank hold PJP as of Q1 2015.

Deutsche Bank reported no remaining Invesco Pharmaceuticals ETF position as of Q1 2015 after selling out during the quarter.
Deutsche Bank sold 2,250 Invesco Pharmaceuticals ETF shares in Q1 2015, an estimated $149K.
Deutsche Bank first reported a position in Invesco Pharmaceuticals ETF in Q2 2013 and held it in 7 quarters.
Deutsche Bank's Invesco Pharmaceuticals ETF position peaked at $1M in Q3 2013.
105 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q1 2015.

Based on Deutsche Bank's 13F filing for Q1 2015, filed 15 May 2015.